Sort
78,016 grants matching “breast cancer”
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib
$569,420Shuiying Hu · Ohio State University · R01 · FY2023 · CA
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib
$569,418Shuiying Hu · Ohio State University · R01 · FY2022 · CA
Exploring the link between serine metabolism and epigenetic in lymphoma
$569,395Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Mouse Models of Metastatic Triple-Negative Breast Cancer for Therapeutic Testing
$569,391Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
microRNA expression profiling of benign breast tissue and breast cancer risk
$569,377Thomas E Rohan · Albert Einstein College Of Medicine · R01 · FY2014 · CA
Adoptive T Cell Therapy for the Treatment of HER2 Overexpressing Cancers
$569,354Mary L. Disis · University Of Washington · R01 · FY2009 · CA
Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms
$569,337Youping Deng · University Of Hawaii At Manoa · R01 · FY2021 · CA
Targeting Effector Immune cells to Cancer with Chemically Self-Assembled Nanorings (CSANs)
$569,277Carston R. Wagner · University Of Minnesota · R01 · FY2021 · CA
Genomic and Transcriptomic Analysis of Breast and Ovarian Cancers
$569,270Joellen M. Schildkraut · Emory University · R01 · FY2021 · CA
MIXED.LINEAGE KINASE3 AS A NOVEL TARGET FOR INVASIVE BREAST CANCER
$569,225Michigan State University · · FY2009 · Department of the Army
Cellular functions of Ran GTPase
$569,204Petr Kalab · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer
$569,181Jose M Silva · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Expectancy and Chemotherapy-Induced Nausea
$569,117Joseph A Roscoe · University Of Rochester · R01 · FY2013 · AT
Expectancy and Chemotherapy-Induced Nausea
$569,117Joseph A Roscoe · University Of Rochester · R01 · FY2014 · AT
Expectancy and Chemotherapy-Induced Nausea
$569,117Joseph A Roscoe · University Of Rochester · R01 · FY2015 · AT
Dual Modality X-ray Luminescence CT for in vivo Cancer Imaging
$569,066Lei Xing · Stanford University · R01 · FY2022 · CA
Characterization of human antibodies to sialyl-Lewis A (sLeA) derived from patien
$569,051Wolfgang W Scholz · Mabvax Therapeutics, Inc. · R42 · FY2011 · CA
Engineering Multifunctional Nanoparticles
$569,049Sangeeta N. Bhatia · Massachusetts Institute Of Technology · R01 · FY2009 · CA
MECHANISMS OF NONCODING ENHANCER RNA FUNCTION IN TRIPLE NEGATIVE BREAST CANCER
$569,048University Of North Carolina At Chapel Hill · · FY2019 · Defense Health Agency
NIGHT SHIFT WORKERS AND HORMONE LEVELS IN WOMEN
$569,041Fred Hutchinson Cancer Research Center · R01 · FY2003 · CA
Improving Palliative Care for Patients with Cancer
$569,026Dartmouth College · R01 · FY2003 · CA
ANALYSIS OF GLYCAN STRUCTURAL MODIFICATIONS TO IDENTIFY IMPROVED BIOMARKERS FOR BREAST CANCER DETECTION
$569,009Regents Of The University Of Michigan · · FY2009 · Department of Defense
MRI Radiomic Signatures of DCIS to Optimize Treatment
$569,003Habibollah Rahbar · University Of Washington · R01 · FY2023 · CA
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study
$568,938Leanna J Standish · Bastyr University · R01 · FY2011 · AT
Medical Care Burden of Cancer: System and Data Issues
$568,927Mark Christopher Hornbrook · Kaiser Foundation Research Institute · R01 · FY2008 · CA